CD57+ T cells augment IFN‐γ production in a one‐way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients

To clarify the immune response of CD57+ T cells (most of them are CD8+) in peripheral blood (PB) against alloantigens in order to elucidate the T helper 1 (Th 1) immune response, we assessed the role of CD57+ T cells in IFN‐γ (one of the representative Th 1 cytokines) production in a one‐way mixed lymphocyte reaction (MLR). In this study, we showed that CD57+ T cells in responder cells were essential for effective IFN‐γ production in allogeneic MLR due partly to the augmentation of the alloresponse of regular T cells. Furthermore, IFN‐γ production in MLR correlated with the proportions of CD57+ T cells in PB regardless of the responders’ age. We also showed that the extent of the expansion of CD57+ T cells in paediatric patients after haematopoietic stem cell transplantation (HSCT) was markedly lower than that in adult patients. In addition, CD57+ T cells purified and activated with a combination of cytokines showed a greater cytotoxicity than regular T cells against human umbilical vein endothelial cells. Because IFN‐γ production in one‐way MLR is a useful predictor of graft‐versus‐host disease (GVHD), especially in the acute phase that occurs after allogeneic HSCT, our findings suggested that CD57+ T cells play a role in the development of GVHD and thus may explain the reason as to why a higher donor age is associated with an increased risk of developing GVHD while, in addition, the incidence of severe GVHD in paediatric patients is lower than that in adult patients.

[1]  C. Miyaji,et al.  Numerical and Functional Characteristics of Lymphocyte Subsets in Centenarians , 1997, Journal of Clinical Immunology.

[2]  M. Ritter,et al.  Optimal analysis of composite cytokine responses during alloreactivity. , 2002, Journal of immunological methods.

[3]  S. Seki,et al.  Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells , 2001, Immunology.

[4]  I. Sekine,et al.  Inhibitory effect of serine protease inhibitors on neutrophil‐mediated endothelial cell injury , 2001, Journal of leukocyte biology.

[5]  H. Mochizuki,et al.  Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma , 2000, Hepatology.

[6]  K. Takeda,et al.  The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses , 2000, Immunological reviews.

[7]  T. Abo,et al.  Physiological responses of extrathymic T cells in the liver , 2000, Immunological reviews.

[8]  M. Steiner,et al.  Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation , 2000, Bone Marrow Transplantation.

[9]  K. Sullivan,et al.  Pathophysiology and treatment of graft-versus-host disease. , 1999, Hematology/oncology clinics of North America.

[10]  R. Storb,et al.  A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. , 1999, Blood.

[11]  D. Doherty,et al.  The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.

[12]  I. Joosten,et al.  Interferon‐γ‐based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings , 1999, British journal of haematology.

[13]  P. Vandenberghe,et al.  CD57+/CD28− T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis , 1998, Leukemia.

[14]  T. Klingebiel,et al.  GVHD: overview on pathophysiology, incidence, clinical and biological features. , 1998, Bone marrow transplantation.

[15]  G. Trinchieri Proinflammatory and immunoregulatory functions of interleukin-12. , 1998, International reviews of immunology.

[16]  D. Dimitrov,et al.  Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. , 1997, Blood.

[17]  E. Holler,et al.  Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease , 1997, Bone Marrow Transplantation.

[18]  D. Stroncek,et al.  Composition of peripheral blood progenitor cell components collected from healthy donors , 1997, Transfusion.

[19]  K. Takeda,et al.  Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. , 1996, Journal of immunology.

[20]  L. Rink,et al.  Interferon-gamma plays a key role in the human mixed lymphocyte culture. , 1996, Bone marrow transplantation.

[21]  K. Hatakeyama,et al.  Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer , 1995, Clinical and experimental immunology.

[22]  R. Truitt,et al.  Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. , 1995, Blood.

[23]  M. Eisner,et al.  Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. , 1995, Bone marrow transplantation.

[24]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[25]  H. Fukuda,et al.  Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.

[26]  F. Sigaux,et al.  Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. , 1994, Blood.

[27]  H. Watanabe,et al.  Extrathymic pathways of T-cell differentiation in the liver and other organs. , 1994, International reviews of immunology.

[28]  C. Hillyer,et al.  CD34+ progenitors and colony‐forming units‐granulocyte macrophage are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriation , 1993, Transfusion.

[29]  R. Truitt,et al.  A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. , 1992, Transplantation.

[30]  E. Unanue,et al.  Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.

[31]  M. Balboa,et al.  Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation , 1990, Clinical and experimental immunology.

[32]  J. Dumler,et al.  Endothelial-cell injury in cutaneous acute graft-versus-host disease. , 1989, The American journal of pathology.

[33]  R. Testi,et al.  Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule , 1989, The Journal of experimental medicine.

[34]  J. Farcet,et al.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. , 1986, Journal of immunology.

[35]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[36]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[37]  H. Deeg,et al.  Bone marrow transplantation in patients aged 45 years and older. , 1986, Blood.

[38]  R. Guttmann,et al.  HNK-1+ (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants. , 1985, Transplantation.

[39]  E. Mellits,et al.  Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. , 1984, Blood.

[40]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[41]  D. Snover,et al.  Hepatic Graft Versus Host Disease: A Study of the Predictive Value of Liver Biopsy in Diagnosis , 1984, Hepatology.

[42]  C. Balch,et al.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.

[43]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.

[44]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.